基于公共数据库分析PEG3基因在肺腺癌中的表达及预后意义
田广伟, 李楠, 李光中国医科大学附属第一医院放疗科, 沈阳 110001
收稿日期:
2019-07-11出版日期:
2020-09-30发布日期:
2020-09-15通讯作者:
李光E-mail:13804058616@163.com作者简介:
田广伟(1985-),男,主治医师,博士.基金资助:
吴阶平医学基金(320.6750.17116)关键词: PEG3, 肺腺癌, 预后, 甲基化, 数据库分析
Abstract: Objective To determine the significance of PEG3 gene expression in the prognosis of lung adenocarcinoma using online databases. Methods PEG3 mRNA expression in lung adenocarcinoma tissue was compared with that in normal lung tissue using The Cancer Genome Atlas (TCGA) database. Correlations between PEG3 expression and clinicopathological parameters relevant for prognosis of adenocarcinoma were determined using LinkedOmics and Kaplan-Meier Plotter. The levels of PEG3 promoter methylation and PEG3-related microRNAs were also assessed. Results The expression of PEG3 mRNA was significantly lower in lung adenocarcinoma than in normal lung tissue. PEG3 expression was correlated with tumor T stage (P=0.003,n=512). The patients with low PEG3 expression had better overall survival than that of patients with high PEG3 expression[HR=0.3,95% CI:0.21-0.43,P<0.001]. PEG3 promoter methylation was significantly higher in lung adenocarcinoma than in normal tissue.PEG3-related microRNAs included miR-124-3p.2/506-3p,miR-124-3p.1,and miR-9-5p. Conclusion PEG3 is downregulated in lung adenocarcinoma. High expression of PEG3 is an important indicator of good prognosis.PEG3-related methylation analysis and microRNA prediction will provide important theoretical basis for future basic research.
Key words: PEG3, lung adenocarcinoma, prognosis, methylation, database analysis
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=2593